AIGH Capital Management’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-106,580	Closed	-$6.84M	–	40
2024 Q3	$6.84M	Buy	106,580 +5,374	+5%	+$354K	3.2%	12
2024 Q2	$6.86M	Buy	101,206 +7,709	+8%	+$740K	3.35%	12
2024 Q1	$11.2M	Buy	93,497 +29,656	+46%	+$3.21M	5.38%	6
2023 Q4	$5.31M	Buy	63,841 +41,257	+183%	+$3.07M	2.1%	19
2023 Q3	$1.79M	Sell	22,584 -4,523	-17%	-$266K	0.85%	33
2023 Q2	$1.59M	Sell	27,107 -3,956	-13%	-$190K	0.65%	33
2023 Q1	$1.34M	Hold	31,063	–	–	0.49%	41
2022 Q4	$1.59M	Buy	31,063 +25,249	+434%	+$1.51M	0.53%	37
2022 Q3	$586K	Sell	5,814 -309	-5%	-$44.4K	0.23%	41
2022 Q2	$1.63M	Hold	6,123	–	–	0.67%	30
2022 Q1	$1.26M	Buy	6,123 +3,134	+105%	+$549K	0.46%	35
2021 Q4	$596K	Buy	+2,989	New	+$720K	0.19%	46